Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCastelnau Group Regulatory News (CGL)

Share Price Information for Castelnau Group (CGL)

Share Price is delayed by 15 minutes
Get Live Data
89.50    0.00 (0.00%)
Bid:
88.00
Ask:
91.00
Spread: 3.00 (3.409%)
Market Cap: £298.49m
CGL Live PriceLast checked at - London Stock Exchange

Intraday Castelnau Group Share Chart

Portfolio Update

27 Dec 2023 12:41

RNS Number : 9603X
Castelnau Group Limited
27 December 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY RESTRICTED JURISDICTION WHERE TO DO SO WOULD CONSTITUTE VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.

 

FOR IMMEDIATE RELEASE.

 

27 December 2023

 

CASTELNAU GROUP LIMITED

(a closed-ended investment company incorporated in Guernsey with registration number 67529)

("Castelnau" or the "Company")

LEI Number: 213800PED8RFUBMK1T64

 

Portfolio Update

 

The Company notes the public statements released by Stanley Gibbons Ltd ("SG") and A.H. Baldwins & Sons Ltd ("AHB") that SG and AHB have, on Friday 22 December 2023, filed a notice of appointment of an administrator. The Company has an interest in SG and AHB through its ownership of Phoenix S.G. Ltd ("Phoenix SG") which at 30 November 2023 comprised 7.8% of its portfolio (9.8% of NAV). The administration will be conducted as a pre-pack and for the avoidance of doubt, Phoenix SG will be the resultant owner through a wholly owned subsidiary, PSG Holdco 1 Limited. The impact of the notice will be reflected in a reduction in the valuation of the Phoenix SG holding at 31 December 2023. Each of the Castelnau portfolio companies are subject to re-valuation at 31 December 2023 and, notwithstanding this reduction in value of Phoenix SG, the Company is not anticipating an overall reduction in net asset value per share. Phoenix SG will continue to support the SG and AHB businesses going forward, which we believe have an exciting growth strategy.

 

Enquiries

 

Castelnau Group

info@castelnaugroup.com

 

Liberum Capital Limited

+44 (0) 20 3100 2000

Darren Vickers

Owen Matthews

Will King

 

Citigate Dewe Rogerson

+44 (0) 20 7638 9571

Caroline Merrell

Toby Moore

 

Notes to Editors

 

Castelnau Group Limited ("CGL") is a Guernsey closed-ended company listed on the Specialist Fund Segment of the London Stock Exchange. Formed by Phoenix Asset Management Partners Limited in 2020, its listed structure provides the manager with a permanent capital vehicle with which to make long-term investments and acquisitions in public and private businesses of all structures and sizes. It's investment philosophy involves acquiring large stakes in, and capital to, businesses that have, or can create, strong competitive advantages. Castelnau Group's portfolio comprises investments in Valderrama (Dignity), Hornby Plc, Stanley Gibbons Group, Showpiece Technologies Limited, Silverwood Brands plc and The Cambium Group, as well as in two `enabling' businesses, Rawnet Limited and Ocula Technologies Limited. 

 

Phoenix Asset Management Partners Limited is the Investment Manager to Castelnau. PAMP has been investing in UK listed equities for 25 years using a long-term, business-focused approach. Its investment process aims to identify great businesses through intensive primary research for which it is well known and can often last many years before choosing to make an investment. Once an investment is made, the investment team maintains this intensive approach to research through in-depth monitoring of the businesses and the markets in which they operate.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFULDLFLXLLXFBK
Date   Source Headline
15th Mar 20135:23 pmRNSAnnual Financial Report
15th Mar 20134:37 pmRNSPrice Monitoring Extension
1st Mar 20132:33 pmRNSTotal Voting Rights
22nd Feb 20132:51 pmRNSHolding(s) in Company
13th Feb 20132:47 pmRNSDirector/PDMR Shareholding
8th Feb 20139:00 amRNSDividend Declaration
8th Feb 20137:00 amRNSAnnual Financial Report
1st Feb 201312:28 pmRNSTotal Voting Rights
2nd Jan 201312:19 pmRNSBlocklisting Interim Review
2nd Jan 201312:17 pmRNSBlocklisting Interim Review
2nd Jan 201312:14 pmRNSTotal Voting Rights
21st Dec 20124:51 pmRNSDirector/PDMR Shareholding
21st Dec 20124:30 pmRNSDirector/PDMR Shareholding
18th Dec 20127:00 amRNSSandy storm estimates
3rd Dec 201212:14 pmRNSTotal Voting Rights
22nd Nov 20128:00 amRNSNew Group Claims Director
22nd Nov 20128:00 amRNSInvestor Day
12th Nov 20127:00 amRNSInterim Management Statement
1st Nov 20124:05 pmRNSTotal Voting Rights
8th Oct 20124:04 pmRNSDirector/PDMR Shareholding
1st Oct 20122:56 pmRNSTotal Voting Rights
25th Sep 201212:00 pmRNSFinancial Calendar
7th Sep 201212:25 pmRNSDirector/PDMR Shareholding
3rd Sep 20122:38 pmRNSTotal Voting Rights
7th Aug 20122:48 pmRNSDirector/PDMR Shareholding
6th Aug 201211:09 amRNSDirector Declaration
6th Aug 20129:59 amRNSDividend Declaration
6th Aug 20127:00 amRNSHalf Yearly Report
1st Aug 201210:49 amRNSTotal Voting Rights
3rd Jul 20127:00 amRNSTotal Voting Rights
2nd Jul 20122:56 pmRNSBlocklisting Interim Review
2nd Jul 20122:54 pmRNSBlocklisting Interim Review
28th Jun 20124:31 pmRNSDirector/PDMR Shareholding
7th Jun 20122:12 pmRNSDirector/PDMR Shareholding
1st Jun 201210:52 amRNSTotal Voting Rights
11th May 20127:00 amRNSInterim Management Statement
1st May 20124:03 pmRNSTotal Voting Rights
12th Apr 201212:08 pmRNSHolding(s) in Company
10th Apr 201212:21 pmRNSAnnual Information Update
2nd Apr 20124:23 pmRNSDirector/PDMR Shareholding
2nd Apr 20124:21 pmRNSTotal Voting Rights
16th Mar 20122:28 pmRNSAnnual Financial Report
13th Mar 20122:29 pmRNSDirector/PDMR Shareholding
1st Mar 20124:19 pmRNSTotal Voting Rights
21st Feb 20123:00 pmRNSDirector/PDMR Shareholding
16th Feb 20124:21 pmRNSDirector/PDMR Shareholding
15th Feb 20125:15 pmRNSDirector/PDMR Shareholding
13th Feb 20123:09 pmRNSDirector/PDMR Shareholding
13th Feb 20123:03 pmRNSDirector/PDMR Shareholding
9th Feb 20129:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.